Meeting Banner
Abstract #1267

In Vivo Characterization of Dietary Effects and Drug Efficacy on Fat Accumulation in Liver, Abdomen and Skeletal Muscle

A Pola1, S Tan2, T Y. Keong3, Z Zhou2, S A. Sadananthan1, G Venkatesh3, S Ishino4, Y Nakano4, M Watanabe4, T Horiguchi4, B Zhu2, S Sendhil Velan3

1Singapoe Institute for Clinical Sciences, A*STAR, Singapore; 2Takeda Singapore Pte Ltd, Singapore; 3Laboratory of Molecular Inaging, Singapore Bioimaging Consortium, Singapore; 4Takeda Pharmaceutical Company Limited, Japan

Current measurements to evaluate the anti-obesity effects are focused on the decrease of the body weight and visceral fat which takes longer time to show the effect, therefore a biomarker to predict anti-obesity effects for short term is of interest. In this study, we investigated the variation in body weight, intra-hepatic lipid, intra-myocellular lipid and visceral fat, in a series of studies using calorie restriction and an anti-obesity drug (Sibutramine) treatment for 4 weeks in a diet induced obese rat model. Our findings demonstrate that MRI/MRS can be utilized to evaluate the therapeutic potential of novel drugs in rodent models of obesity and diabetes.

Keywords

abdomen adipose anti appetite axial beginning blood blue body calorie cardiovascular clinical coils company composition concentration consortium continued contributing control correction days decrease deposit develop developed diabetes diet dietary discover drug eddy employ evaluate fisher fitting food gradual gradually graph gray green hand health in vivo induce induced inhibiting institute insulin intake intra japan lipid liver localized longer male marker measured medical methyl methylene minimal model muscle need normalized novel obese obesity organs period posterior potential predict press presses problems program receive received reduction response restriction rodent sciences segmentation series several sharp short skeletal spectral spectrum spin spine star steady studied subgroup supp takes term tissue transient transmit transverse treatment triglyceride type uptake variation visceral volume water weeks